These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Clinicopathologic manifestation of amiodarone-induced lung injury].
    Author: Shi JH, Liu HR, Zhu YJ, Xu WB.
    Journal: Zhonghua Bing Li Xue Za Zhi; 2006 Jul; 35(7):394-7. PubMed ID: 17069673.
    Abstract:
    OBJECTIVE: To study the clinical, pathologic and radiologic features of amiodarone-induced lung injury. METHODS: The clinical, pathologic and radiologic features, including treatment and follow-up information of three cases diagnosed as amiodarone-induced lung injury from October 2004 to October 2005 in the Peking Union Medical College Hospital were reviewed. RESULTS: All the patients were males, with age ranging from 35 to 64 years. The duration of symptoms varied from 20 days to 3 years. All presented with cough. Worsening dyspnea and inspiratory crackles were noted in two patients. Computerized tomography showed bilateral patchy infiltration, ground-glass appearance and accentuation of bronchovascular markings. The most common pathologic manifestations included cellular interstitial pneumonia associated with intra-alveolar collections of macrophages and type II pneumocyte hyperplasia. Some of the macrophages contained finely vacuolated cytoplasm. An organizing pneumonia pattern was seen in one patient. CONCLUSIONS: Amiodarone-induced lung injury has characteristic pathologic features which may provide clues to diagnosis. Correlation with clinical and radiologic findings is also important.
    [Abstract] [Full Text] [Related] [New Search]